newsfilter
← Latest News
GlobeNewswire·

Acer Therapeutics Reports Q4 and Full Year 2022 Financial Results and Provides Corporate Update

NEWTON, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (NASDAQ:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and